Oh SJ

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (8)

Title : Maximization of 3-hydroxyhexanoate fraction in poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) using lauric acid with engineered Cupriavidus necator H16 - Oh_2023_Int.J.Biol.Macromol_256_128376
Author(s) : Oh SJ , Choi TR , Kim HJ , Shin N , Hwang JH , Bhatia SK , Kim W , Yeon YJ , Yang YH
Ref : Int J Biol Macromol , 256 :128376 , 2023
Abstract : Oh_2023_Int.J.Biol.Macromol_256_128376
ESTHER : Oh_2023_Int.J.Biol.Macromol_256_128376
PubMedSearch : Oh_2023_Int.J.Biol.Macromol_256_128376
PubMedID: 38007029

Title : Revealing the key gene involved in bioplastic degradation from superior bioplastic degrader Bacillus sp. JY35 - Kim_2023_Int.J.Biol.Macromol_244_125298
Author(s) : Kim SH , Cho JY , Nara S , Hwang JH , Kim HJ , Oh SJ , Bhatia SK , Yun J , Lee SH , Yang YH
Ref : Int J Biol Macromol , 244 :125298 , 2023
Abstract : Kim_2023_Int.J.Biol.Macromol_244_125298
ESTHER : Kim_2023_Int.J.Biol.Macromol_244_125298
PubMedSearch : Kim_2023_Int.J.Biol.Macromol_244_125298
PubMedID: 37315675
Gene_locus related to this paper: bacpu-q6rsn0

Title : Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease - Park_2019_Sci.Adv_5_eaav0316
Author(s) : Park JH , Ju YH , Choi JW , Song HJ , Jang BK , Woo J , Chun H , Kim HJ , Shin SJ , Yarishkin O , Jo S , Park M , Yeon SK , Kim S , Kim J , Nam MH , Londhe AM , Cho SJ , Cho S , Lee C , Hwang SY , Kim SW , Oh SJ , Cho J , Pae AN , Lee CJ , Park KD
Ref : Sci Adv , 5 :eaav0316 , 2019
Abstract : Park_2019_Sci.Adv_5_eaav0316
ESTHER : Park_2019_Sci.Adv_5_eaav0316
PubMedSearch : Park_2019_Sci.Adv_5_eaav0316
PubMedID: 30906861

Title : Congenital Myasthenic Syndromes - Shieh_2018_Neurol.Clin_36_367
Author(s) : Shieh PB , Oh SJ
Ref : Neurol Clin , 36 :367 , 2018
Abstract : Shieh_2018_Neurol.Clin_36_367
ESTHER : Shieh_2018_Neurol.Clin_36_367
PubMedSearch : Shieh_2018_Neurol.Clin_36_367
PubMedID: 29655455

Title : Myasthenia gravis Lambert-Eaton overlap syndrome - Oh_2016_Muscle.Nerve_53_20
Author(s) : Oh SJ
Ref : Muscle & Nerve , 53 :20 , 2016
Abstract : Oh_2016_Muscle.Nerve_53_20
ESTHER : Oh_2016_Muscle.Nerve_53_20
PubMedSearch : Oh_2016_Muscle.Nerve_53_20
PubMedID: 26418033

Title : The genome sequence of the ethanologenic bacterium Zymomonas mobilis ZM4 - Seo_2005_Nat.Biotechnol_23_63
Author(s) : Seo JS , Chong H , Park HS , Yoon KO , Jung C , Kim JJ , Hong JH , Kim H , Kim JH , Kil JI , Park CJ , Oh HM , Lee JS , Jin SJ , Um HW , Lee HJ , Oh SJ , Kim JY , Kang HL , Lee SY , Lee KJ , Kang HS
Ref : Nat Biotechnol , 23 :63 , 2005
Abstract : Seo_2005_Nat.Biotechnol_23_63
ESTHER : Seo_2005_Nat.Biotechnol_23_63
PubMedSearch : Seo_2005_Nat.Biotechnol_23_63
PubMedID: 15592456
Gene_locus related to this paper: zymmo-DLH , zymmo-GAA , zymmo-metx , zymmo-q5nkz4 , zymmo-q5nmh0 , zymmo-q5nmm8 , zymmo-q5nmn0 , zymmo-q5nmz5 , zymmo-q5nnu4 , zymmo-q5npe2 , zymmo-q5nph2 , zymmo-q5npn6 , zymmo-q5nq91 , zymmo-q5nrh7 , zymmo-q5nnr5

Title : Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome - Oh_1997_Muscle.Nerve_20_1146
Author(s) : Oh SJ , Kim DS , Head TC , Claussen GC
Ref : Muscle & Nerve , 20 :1146 , 1997
Abstract : Oh_1997_Muscle.Nerve_20_1146
ESTHER : Oh_1997_Muscle.Nerve_20_1146
PubMedSearch : Oh_1997_Muscle.Nerve_20_1146
PubMedID: 9270671

Title : Humoral immunity in myasthenia gravis: relationship to disease severity and steroid treatment -
Author(s) : Bradley RJ , Dwyer D , Morley BJ , Robinson G , Kemp GE , Oh SJ
Ref : Prog Brain Res , 49 :441 , 1979
PubMedID: 515441